CD8-ALN2

N/A

Report date: 2025/06/11 10:53:18

Base Information

Drug NameCD8-ALN2
Drug Alias NameCD8 T cell-targeted IL-2 (Orionis Biosciences)
ClassificationBiologics
Mechanisms of ActionImmunostimulantsInterleukin-2 receptor agonistsT lymphocytes stimulants
TargetsInterleukin-2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrionis Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrionis Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A